Search clinical trials for: Attention Deficit Disorder with Hyperactivity -- drug therapy

Total 381861 results

University of Alberta
The University of Queensland

Withdrawn

Melatonin in Youth: N-of-1 Trials in a Stimulant-treated Attention Deficit Hyperactivity Disorder (ADHD) Population (MYNAP)

Attention Deficit/Hyperactivity Disorder | Initial Insomnia

Canada
Hospices Civils de Lyon

Terminated

Psychometric Validation of the Competitive Attention Test (CAT)

Attention Deficit Hyperactivity Disorder

France
Otsuka Pharmaceutical Development & Commercialization...

Completed

The Safety and Efficacy of OPC-64005 in the Treatment of Adult Attention-deficit/Hyperactivity Disorder

Adult Attention Deficit Hyperactivity Disorder

United States
Supernus Pharmaceuticals, Inc.

Completed

Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD

Attention-Deficit/Hyperactivity Disorder (ADHD)

United States
Shire

Completed

Drug Use Study With Intuniv® in Australia

Attention Deficit Hyperactivity Disorder (ADHD)

Australia
Biruni University

Completed

Cognitive Intervention in Attention Deficit and Hyperactivity Disorder

ADHD | Cognitive Deficit

Turkey
Purdue Pharma, Canada

Completed

Real World Evidence of the Efficacy and Safety of FOQUEST (reFOQus)

Attention Deficit-Hyperactivity Disorder

Canada
National Taiwan University Hospital
National Science Council, Taiwan

Completed

Molecular Studies on the Candidate Genes of Dopaminergic and Noradrenergic Systems in ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
National Taiwan University Hospital
National Health Research Institutes, Taiwan

Completed

The Association Between Executive Functions and Candidate Genes of Dopaminergic and Noradrenergic Systems in Attention Deficit Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Taiwan
National Taiwan University Hospital

Completed

The Effectiveness of Atomoxetine on Brain Imaging, Neuropsychological, and Social Functions in Adults ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
National Taiwan University Hospital

Completed

Neuropsychology, Neuroimage and Neurophysiology in Adults With ADHD

Attention Deficit Hyperactivity Disorder

Taiwan
National Taiwan University Hospital
National Science Council, Taiwan

Completed

Pharmacogenetic Studies on Attention Deficit Hyperactivity Disorder

Attention Deficit Hyperactivity Disorder

Taiwan
Shire

Completed

Safety of SPD465 in Treating Adults With ADHD.

Attention Deficit Disorder With Hyperactivity
Aevi Genomic Medicine, LLC, a Cerecor company

Completed

Efficacy and Safety of NFC-1 in Adolescents With Genetic Disorders Impacting mGluR and ADHD

Attention Deficit Disorder With Hyperactivity

United States
Aarhus University Hospital
Takeda

Active, not recruiting

The Use of Lisdexamfetamine for Children Aged 7-13 With Attention Deficit Disorders

Attention Deficit Hyperactivity Disorder | Attention Deficit Disorder | Hyperkinetic Disorder

Denmark
Ironshore Pharmaceuticals and Development, Inc

Completed

A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting

Attention Deficit Hyperactivity Disorder

United States
Ironshore Pharmaceuticals and Development, Inc

Completed

A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Classroom Setting

Attention Deficit Hyperactivity Disorder

United States
Chang Gung Memorial Hospital

Enrolling by invitation

Endocrine Disrupting Chemicals and Hormones in ADHD (ADHD)

Attention Deficit Hyperactivity Disorder

Taiwan
Ironshore Pharmaceuticals and Development, Inc

Completed

A Study of Delayed and Extended Release Formulation of Dextroamphetamine Sulfate (HLD100) in Children With ADHD (HLD100-103)

Attention-Deficit Hyperactivity Disorder (ADHD)

United States
Shire

Completed

Efficacy and Safety of SPD465 in Adults With Moderately Symptomatic ADHD.

Attention Deficit Disorder With Hyperactivity
Shire

Completed

Efficacy and Safety of Extended-release Guanfacine Hydrochloride in Children and Adolescents Aged 6-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

Spain, United States, Germany, Poland, Italy, Ukraine, Romania, United Kingdom, Sweden, Austria, Canada, France, Ireland
Shire

Completed

Efficacy and Safety of SPD465 in Adults With ADHD

Attention Deficit Disorder With Hyperactivity
Shire

Completed

Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl

Attention-Deficit/Hyperactivity Disorder

United States
Gregory Fabiano

Completed

Efficacy of Lisdexamfetamine Dimesylate for Promoting Occupational Success in Young Adults With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Shire

Completed

Safety and Efficacy of SPD465 in Adults With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Shire

Completed

Safety and Efficacy of Vyvanse in Adults With Attention-Deficit/Hyperactivity Disorder

Attention-Deficit/Hyperactivity Disorder

United States
Shire

Completed

Access to Extended Release Guanfacine HCl for Subjects Who Participated in Studies SPD503-315 or SPD503-316 in Europe

Attention Deficit Hyperactivity Disorder (ADHD)

Spain, Germany, Ukraine, France, Italy, Austria, Belgium, Ireland, Netherlands, Poland, Romania, Sweden, United Kingdom
Shire

Completed

A Classroom Study to Assess the Time of Onset of Vyvanse (Lisdexamfetamine Dimesylate) in Pediatric Subjects Aged 6-12 With Attention Deficit/Hyperactivity Disorder (ADHD)

ADHD

United States
Shire

Completed

Lisdexamfetamine Dimesylate (LDX) Pilot Cognition Study to Evaluate the Utility of a Standardized Battery of Tests in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

Attention-Deficit Hyperactivity Disorder

United States
Shire

Completed

Maintenance of Efficacy of Extended-Release Guanfacine HCl in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)

Attention-deficit/Hyperactivity Disorder

Spain, Belgium, United States, Netherlands, United Kingdom, Italy, Germany, Canada, France, Sweden
Shire

Completed

Efficacy and Safety of Lisdexamfetamine Dimesylate (LDX) in Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Shire

Completed

Comparison of Lisdexamfetamine Dimesylate With Atomoxetine HCl in Attention-Deficit/Hyperactivity Disorder (ADHD) Subjects With an Inadequate Response to Methylphenidate

Attention-Deficit/Hyperactivity Disorder

United States, Poland, Spain, Canada, Hungary, Belgium, Germany, Italy, Sweden, United Kingdom
Shire

Completed

Safety and Efficacy of SPD503 in Treating Attention-Deficit/Hyperactivity Disorder (ADHD) in Children Aged 6-17

Attention Deficit Disorder With Hyperactivity
Shire

Completed

Lisdexamfetamine Dimesylate 2-year Safety Study in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

Germany, Italy, Poland, Spain, Romania, Belgium, Hungary, Netherlands, Sweden, United Kingdom
Shire

Completed

Safety, Tolerability and Efficacy of SPD503 in Treating ADHD in Children Aged 6-17

Attention Deficit Disorder With Hyperactivity
Shire

Completed

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

Attention-deficit/Hyperactivity Disorder

United States, Canada, Germany, Hungary, Sweden
Shire

Completed

Safety and Efficacy of SPD503 in Treating ADHD in Children and Adolescents Aged 6-17

Attention Deficit Disorder With Hyperactivity
Shire

Completed

Safety and Tolerability of SPD503 and Psychostimulants in Children and Adolescents Aged 6-17 With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Disorder With Hyperactivity
Shire

Completed

Safety and Efficacy Workplace Environment Study of Lisdexamfetamine Dimesylate (LDX) in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)

ADHD

United States
Shire

Completed

Safety and Efficacy of SPD489 on Executive Function Behaviors in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)

ADHD Specifically With Executive Function Impairment

United States
Shire

Completed

Tolerability and Efficacy of AM and PM Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Children 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) (The ADHD Tempo Study)

Attention-Deficit/Hyperactivity Disorder

United States, Canada
Shire

Completed

Safety, Tolerability and Pharmacokinetics of SHP465 in Children Aged 4 to 5 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Shire

Completed

Effectiveness of Vyvanse Compared to Concerta in Adolescents With Attention-deficit/Hyperactivity Disorder

Attention-deficit/Hyperactivity Disorder

United States
Shire

Completed

Safety and Efficacy Study in Preschool Children Aged 4-5 Years With Attention-deficit/Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Shire

Completed

Safety and Efficacy of ADDERALL XR in the Treatment of Adolescents Aged 13-17 With Attention Deficit Hyperactivity Disorder (ADHD)

ADHD

United States
Shire

Completed

The Safety and Efficacy of SPD465 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Attention-Deficit/Hyperactivity Disorder
Shire

Withdrawn

Safety and Efficacy of SPD489 in Adolescent Subjects Aged 13-17 Years With Attention-Deficit/Hyperactivity Disorder (ADHD)

ADHD

United States
Shire

Completed

ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD

Attention Deficit Disorder With Hyperactivity

United States
Shire

Completed

Pharmacokinetic Study in Children and Adolescents Aged 6 to 17 Years Who Have Been Diagnosed With ADHD

Attention Deficit Hyperactivity Disorder (ADHD)

United States
Children's Hospital Medical Center, Cincinnati
National Institute of Mental Health (NIMH)

Completed

Attention Deficit Disorder Medication Response Study

ADHD - Combined Type | ADHD - Inattentive Type

United States

3

Subscribe